Crossmark

Safety and efficacy of ruxolitinib in a profoundly thrombocytopenic patient with myelofibrosis

Crossref DOI link: https://doi.org/10.1007/s00277-014-2241-7

Published Online: 2014-11-25

Published Print: 2015-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Armstrong, C.

Maung, S. W.

Neary, P.

McHugh, J.

Enright, H.
License Information

Text and Data Mining valid from 2014-11-25